DCF — SARAH BUSH LINCOLN HEALTH CENTER
Enterprise Value: $-1.2B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.2B
Enterprise Value
$-374.2M
PV of Cash Flows
$-840.3M
PV of Terminal Value
$-1.4B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $462.1M | $-81.1M | -18.0% | $-100.7M | $-91.5M |
| Year 2 | $475.9M | $-78.8M | -17.0% | $-99.0M | $-81.8M |
| Year 3 | $490.2M | $-76.3M | -16.0% | $-97.0M | $-72.9M |
| Year 4 | $504.9M | $-76.0M | -15.0% | $-97.4M | $-66.5M |
| Year 5 | $520.0M | $-77.0M | -15.0% | $-99.0M | $-61.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.2B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$448.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.18058619913352564
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5